These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22417220)

  • 41. Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075).
    Riley RJ; Hemingway SA; Graham MA; Workman P
    Biochem Pharmacol; 1993 Mar; 45(5):1065-77. PubMed ID: 8461036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia.
    Okuda K; Okabe Y; Kadonosono T; Ueno T; Youssif BG; Kizaka-Kondoh S; Nagasawa H
    Bioconjug Chem; 2012 Mar; 23(3):324-9. PubMed ID: 22335430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.
    Walton MI; Wolf CR; Workman P
    Biochem Pharmacol; 1992 Jul; 44(2):251-9. PubMed ID: 1642640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia.
    Wang J; Foehrenbacher A; Su J; Patel R; Hay MP; Hicks KO; Wilson WR
    Clin Cancer Res; 2012 Mar; 18(6):1684-95. PubMed ID: 22167409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
    Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
    Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzymatic and nonenzymatic production of free radicals from the carcinogens 4-nitroquinoline N-oxide and 4-hydroxylaminoquinoline N-oxide.
    Fann YC; Metosh-Dickey CA; Winston GW; Sygula A; Rao DN; Kadiiska MB; Mason RP
    Chem Res Toxicol; 1999 May; 12(5):450-8. PubMed ID: 10328756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Nitronaphthalimide Probe for Fluorescence Imaging of Hypoxia in Cancer Cells.
    Kumari R; R V; Sunil D; Ningthoujam RS; Pandey BN; Kulkarni SD; Varadavenkatesan T; Venkatachalam G; V AKN
    J Fluoresc; 2021 Nov; 31(6):1665-1673. PubMed ID: 34383168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.
    Elwell JH; Siim BG; Evans JW; Brown JM
    Biochem Pharmacol; 1997 Jul; 54(2):249-57. PubMed ID: 9271329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.
    Jain M; Kwon CH
    J Med Chem; 2003 Dec; 46(25):5428-36. PubMed ID: 14640551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Povarov-reductive amination cascade to access 6-aminoquinolines and anthrazolines.
    Pericherla K; Kumar A; Jha A
    Org Lett; 2013 Aug; 15(16):4078-81. PubMed ID: 23889262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the mechanistic aspects of mitomycin antibiotic bioactivation in Chinese hamster ovary cells overexpressing NADPH:cytochrome C (P-450) reductase and DT-diaphorase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Adv Enzyme Regul; 1998; 38():111-33. PubMed ID: 9762350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
    Plumb JA; Gerritsen M; Workman P
    Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.
    Zhang H; Gruenke L; Arscott D; Shen A; Kasper C; Harris DL; Glavanovich M; Johnson R; Waskell L
    Biochemistry; 2003 Oct; 42(40):11594-603. PubMed ID: 14529269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electron transfer in human methionine synthase reductase studied by stopped-flow spectrophotometry.
    Wolthers KR; Scrutton NS
    Biochemistry; 2004 Jan; 43(2):490-500. PubMed ID: 14717604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitroreductase detection and hypoxic tumor cell imaging by a designed sensitive and selective fluorescent probe, 7-[(5-nitrofuran-2-yl)methoxy]-3H-phenoxazin-3-one.
    Li Z; Li X; Gao X; Zhang Y; Shi W; Ma H
    Anal Chem; 2013 Apr; 85(8):3926-32. PubMed ID: 23506563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A.
    Gu Y; Patterson AV; Atwell GJ; Chernikova SB; Brown JM; Thompson LH; Wilson WR
    Mol Cancer Ther; 2009 Jun; 8(6):1714-23. PubMed ID: 19509245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, and biological evaluation of pyrrolobenzodiazepine-containing hypoxia-activated prodrugs.
    Dragovich PS; Broccatelli F; Chen J; Fan P; Le H; Mao W; Pillow TH; Polson AG; Wai J; Xu Z; Yao H; Zhang D
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5300-5304. PubMed ID: 29079474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive binding.
    Liu Y; Xu Y; Qian X; Liu J; Shen L; Li J; Zhang Y
    Bioorg Med Chem; 2006 May; 14(9):2935-41. PubMed ID: 16403640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorescent markers for hypoxic cells: a study of nitroaromatic compounds, with fluorescent heterocyclic side chains, that undergo bioreductive binding.
    Hodgkiss RJ; Jones GW; Long A; Middleton RW; Parrick J; Stratford MR; Wardman P; Wilson GD
    J Med Chem; 1991 Jul; 34(7):2268-74. PubMed ID: 2066999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.